Form 4 for ELAN Elanco Animal Health Inc

Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001752439-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2026-03-03	2026-03-01	ELAN	Kinard David S	SEE REMARKS	A - Grant	$0.00	+42.6K	223.6K	+24%	$0
D	2026-03-03	2026-03-01	ELAN	Kinard David S	SEE REMARKS	F - Tax	$26.40	-15.4K	208.2K	-7%	-$406.0K
D	2026-03-03	2026-03-01	ELAN	Kinard David S	SEE REMARKS	A - Grant	$0.00	+19.4K	19.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-01	A	A	9,470	$0.00	217,697	D	—	—	(F2) Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
2	Common	Common Stock	2026-03-01	F	D	15,377	$26.40	208,227	D	—	—
3	Common	Common Stock	2026-03-01	A	A	33,087	$0.00	223,604	D	—	—	(F1) Includes 648 shares acquired on April 30, 2025, 518 shares acquired on July 31, 2025, 221 shares acquired on October 31, 2025, and 252 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .
4	Derivative	Employee Stock Option (right to buy)	2026-03-01	A	A	19,350	$0.00	19,350	D	$26.40 · — to 2036-03-01	19,350 Common Stock	(F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.